GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Aspira Womens Health Inc (FRA:CUL) » Definitions » Shiller PE Ratio

Aspira Womens Health (FRA:CUL) Shiller PE Ratio : (As of May. 24, 2024)


View and export this data going back to . Start your Free Trial

What is Aspira Womens Health Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Aspira Womens Health Shiller PE Ratio Historical Data

The historical data trend for Aspira Womens Health's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aspira Womens Health Shiller PE Ratio Chart

Aspira Womens Health Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Aspira Womens Health Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Aspira Womens Health's Shiller PE Ratio

For the Diagnostics & Research subindustry, Aspira Womens Health's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aspira Womens Health's Shiller PE Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Aspira Womens Health's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Aspira Womens Health's Shiller PE Ratio falls into.



Aspira Womens Health Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Aspira Womens Health's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Aspira Womens Health's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.359/131.7762*131.7762
=-0.359

Current CPI (Mar. 2024) = 131.7762.

Aspira Womens Health Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 -1.656 100.560 -2.170
201409 -1.862 100.428 -2.443
201412 -1.338 99.070 -1.780
201503 -1.386 99.621 -1.833
201506 -1.470 100.684 -1.924
201509 -1.336 100.392 -1.754
201512 -1.377 99.792 -1.818
201603 -1.212 100.470 -1.590
201606 -0.935 101.688 -1.212
201609 -0.936 101.861 -1.211
201612 -0.711 101.863 -0.920
201703 -0.701 102.862 -0.898
201706 -0.534 103.349 -0.681
201709 -0.755 104.136 -0.955
201712 -0.634 104.011 -0.803
201803 -0.608 105.290 -0.761
201806 -0.514 106.317 -0.637
201809 -0.514 106.507 -0.636
201812 -0.527 105.998 -0.655
201903 -0.664 107.251 -0.816
201906 -0.797 108.070 -0.972
201909 -0.545 108.329 -0.663
201912 -0.405 108.420 -0.492
202003 -0.543 108.902 -0.657
202006 -0.533 108.767 -0.646
202009 -0.509 109.815 -0.611
202012 -7.151 109.897 -8.575
202103 -0.630 111.754 -0.743
202106 -0.747 114.631 -0.859
202109 -1.148 115.734 -1.307
202112 -1.124 117.630 -1.259
202203 -1.126 121.301 -1.223
202206 -1.041 125.017 -1.097
202209 -1.010 125.227 -1.063
202212 -0.566 125.222 -0.596
202303 -0.738 127.348 -0.764
202306 -0.258 128.729 -0.264
202309 -0.450 129.860 -0.457
202312 -0.275 129.419 -0.280
202403 -0.359 131.776 -0.359

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Aspira Womens Health  (FRA:CUL) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Aspira Womens Health Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Aspira Womens Health's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Aspira Womens Health (FRA:CUL) Business Description

Traded in Other Exchanges
Address
12117 Bee Caves Road, Suite 100, Building 3, Austin, TX, USA, 78738
Aspira Womens Health Inc is engaged in developing and commercializing diagnostic tests for gynecologic diseases. The Company markets and sells, 1) Ova1, a blood test intended as an aid to assess the likelihood of malignancy in women with an ovarian adnexal mass for which surgery is planned when the physician's independent clinical and radiological evaluation does not indicate malignancy; (2) Overa, a second-generation biomarker reflex intended to maintain Ova1's high sensitivity while improving specificity; (3) Ova1Plus, a reflex offering which uses Ova1 as the primary test and Overa as a confirmation for Ova1 intermediate range results; and (4) OvaWatch, a lab-developed blood test intended to assist in the initial clinical assessment of malignancy risk in all women with an adnexal mass.

Aspira Womens Health (FRA:CUL) Headlines

No Headlines